Login / Signup

Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter.

Jorge Magdaleno TapialSergio Santos-AlarcónMarta Carolina Serra-TorresLuca Schneller-PavelescuCristina López-MartíJosé-María Ortiz-SalvadorPablo Hernández-BelJosé Luis Sánchez-CarazoAmparo Pérez-Ferriols
Published in: Dermatologic therapy (2022)
Keyphrases
  • disease activity
  • clinical practice
  • systemic lupus erythematosus
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • ankylosing spondylitis
  • juvenile idiopathic arthritis
  • atopic dermatitis